Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.
Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Toby A
0000-0002-6631-9749
TA
Eyre
Department of Haematology, Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK.
Wendy L
WL
Osborne
Velindre Cancer Centre, Cardiff, UK.
Eve
E
Gallop-Evans
Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
Kirit M
KM
Ardeshna
Department of Haematology, Kings College London Hospitals NHS Foundation Trust Denmark Hill, London, UK.
Shireen
0000-0002-6173-3326
S
Kassam
Department of Haematology, James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK.
Shalal
S
Sadullah
Department of Haematology, Lincoln County Hospital, Lincoln, UK.
Gamal
G
Sidra
Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, UK.
Dominic
D
Culligan
Department of Haematology, Royal Liverpool University Hospital NHS Trust, Liverpool, UK.
Arvind
A
Arumainathan
Department of Haematology & Stem Cell Transplantation, Birmingham Heartlands Hospital, Birmingham, UK.
Paneesha
P
Shankara
Department of Haematology, Norfolk and Norwich University Hospital, Norwich, UK.
Kristian M
KM
Bowles
Nuffield Department of Medicine, University of Oxford, Oxford, UK.
David W
DW
Eyre
Department of Haematology, St George's Hospital, Oxford, UK.
Ying Y
YY
Peng
Department of Haematology, St George's Hospital, Oxford, UK.
Ruth
R
Pettengell
Department of Haematology, The Christie Hospital NHS Trust, Manchester, UK.
Adrian
A
Bloor
Department of Haematology, St James's Hospital and Trinity College, Dublin, Ireland.
Elisabeth
E
Vandenberghe
Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Graham P
GP
Collins
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy* / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D011687:Purines / Q000008:administration & dosage*; D052999:Quinazolinones / Q000008:administration & dosage*; D012008:Recurrence; D015996:Survival Rate; D006113:United Kingdom / Q000453:epidemiology
D011687:Purines; D052999:Quinazolinones; C552946:idelalisib
PI3K; follicular lymphoma; idelalisib